

소개
In vitro, in vivo, and in silico preclinical models hold a widely acknowledged potential, yet complex limitations. For this reason, which has been known for a long time by experimenters and modelers, the translation of "science products" to the clinic is still far. Therefore, there is a raising awareness of the need to bridge this gap by developing integrated and innovative models.



